Fenwick & West represented Freenome in the transaction. Freenome, a biotechnology company developing blood tests for early cancer detection, announced the addition of $254 million from...
Freenome’s $254 Million Funding Round
Freenome’s $300 Million Series D Financing
Fenwick & West advised Freenome on the deal. Freenome, a privately held biotechnology company, announced its $300million Series D financing. The round was led by investors Perceptive...